For over ten years, our company has been developing technology for completely non-contact and non-invasive blood test information measurement, grounded in mathematical and neuroscientific principles.
On August 29, 2025, we will present our technology at the Annual Meeting of the Japanese Association of Clinical Laboratory Medicine, and starting from the end of September 2025, we will begin releasing our proprietary application, “FLD HbA1c,” which is capable of simultaneously measuring HbA1c/pulse/oxygen saturation, on our exclusive platform, the SFM App Store.
We are pleased to announce that development of the Android version of our LDL cholesterol measurement application, which will facilitate non-contact and non-invasive measurement and be presented at a conference next year, has been completed.
The application enables measurement on devices such as Google Pixel, similarly to FLD HbA1c, allowing for completely non-contact and non-invasive measurements.
Going forward, we will continue to strive for greater accuracy in preparation for general market release and other developments.
Further details regarding the release of this application will be announced as they are finalized.
We will inform you accordingly once applications for other items, including the iOS version, are completed.